1st approved Symbicort generic, Breyna, now available in US
Aug 7, 2023 · The inhaled medication — the first Symbicort generic to be approved by the U.S. Food and Drug Administration — will become immediately available to eligible patients.. Like …
A form of vitamin B3 lowers COPD lung inflammation: Study
Nov 25, 2024 · Assessing inflammation with vitamin B supplement. The University of Copenhagen launched a single-center trial (NCT04990869) at the Respiratory Research Unit at Bispebjerg …
Low-dose Morphine Improves Health in COPD Patients With …
Sep 3, 2020 · So, researchers based at the Maastricht University in the Netherlands designed the Morphine for Treatment of Dyspnea in Patients With COPD (MORDYC) Phase 4 study …
Dupixent approved in US for adults with poorly controlled COPD
Sep 30, 2024 · In the U.S., the expansion of Dupixent’s label to include COPD brings the number of approved indications up to six, adding to its use as a treatment for atopic dermatitis, …
Ohtuvayre effective across key patient subgroups: ENHANCE trials
Oct 14, 2024 · In an oral presentation titled “Ensifentrine Improved Lung Function, Symptoms, and Quality of Life Regardless of COPD Severity,” Jessica M. Bon, MD, of Wake Forest …
LupinHaler, generic version of Spiriva HandiHaler, available in US
Aug 28, 2023 · In Europe, generics of Boehringer Ingelheim’s Spiriva HandiHaler began launching in 2021, including ones from Glenmark Pharmaceuticals and Phargentis, but these …
Dupixent (dupilumab) for COPD | COPD News Today
Nov 18, 2024 · Dupixent is a biological therapy, or one made from living organisms. It’s designed to target type 2 inflammation — a type of inflammation marked by elevated eosinophils in the …
My worsening COPD symptoms have prompted a change of habits
Oct 30, 2024 · Just how long can a person have low oxygen saturation before damage occurs? The answer is unknown. I feel that any amount of time with low oxygen saturation is too long, …
Ohtuvayre (ensifentrine) for COPD | COPD News Today
Jul 9, 2024 · Sold in the U.S./most regions by Verona Pharma, the nonsteroidal medication is designed to improve lung function and ease symptoms in COPD patients. Verona also is …
FDA approves first RSV vaccine for at-risk adults younger than 50
Oct 28, 2024 · The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly …